Important Safety Information About PRISTIQ
Suicidality and Antidepressant Drugs Antidepressants increased the risk of suicidal thinking and behavior in children, teens, and young adults. Depression and certain other psychiatric disorders are themselves associated with increases in the risk of suicide. Patients of all ages who are started on antidepressant therapy or when the dose is changed should be monitored appropriately and observed closely for clinical worsening, suicidality, or unusual changes in behavior such as becoming agitated, irritable, hostile, aggressive, impulsive, or restless. Should these occur, report them to a doctor right away. PRISTIQ is not approved for use in children under 18.

Do not take PRISTIQ if you are allergic to desvenlafaxine, venlafaxine, or any of the ingredients in PRISTIQ. Do not take PRISTIQ if you currently take, or have taken within the last 14 days, any medicine known as an MAOI (including intravenous methylene blue or the antibiotic linezolid).

File Not Found

The page cannot be found.

The page you are looking for might bave been removed, had its name changed or is temporarily unavailable.


Please try the following:

If you typed the page address in the Address bar, make sure it is spelled correctly.
Open the Pristiq.com home page, and look for links to the information you want.
Click the Back button in your browser to try another link.

HTTP 404 - File not found
Internet Information Services


The health information contained herein is provided for educational purposes only and is not intended to replace discussions with a health care provider. All decisions regarding patient care must be made with a health care provider, considering the unique characteristics of the patient.

The product information provided in this site is intended for residents of the United States. The products discussed herein may have different product labeling in different countries.

 
 
Copyright © 2013 Pfizer Inc. All rights reserved. PQP580408-01